CoreRx on Facebook CoreRx on Twitter CoreRx on LinkedIn
Wednesday, 30 December 2009 00:00

API in Capsule

Common “First in Man” approaches vs. The Lost Art of Formulation Development

In today’s market, pharmaceutical and biotech companies are being asked to do more…with less.  Diminishing resources, pipelines, competition, and increased regulatory hurdles are forcing us to rethink our strategy. We must work smarter, not harder.

Published in Clinical Manufacturing
Monday, 22 February 2010 00:00

Combination Products should be considered

According to Pharmaceutical Technology, there has been a surge in the number of combination product (i.e. where a drug product is combined with a medical device) launches in recent years and this trend is set to continue as more companies seek to extend the life of existing branded medicines.

source logos